NEW YORK (GenomeWeb News) - Invitrogen said this week that it has licensed a set of computationally predicted human and mouse microRNA sequences from Natural Selection, a developer of pattern recognition tools.
Invitrogen said the microRNA sequences have been verified experimentally using deep sequencing, array profiling, and qRT-PCR methods. The firms will submit the sequences to the Wellcome Trust Sanger Institute’s miRNA database and Invitrogen will integrate the sequences into its miRNA arrays.
Under the agreement, Invitrogen will release a larger set of computationally predicted microRNA sequences over the next few years.
Financial terms of the agreement were not released.